[go: up one dir, main page]

AU3836489A - Treatment of immunodeficiency - Google Patents

Treatment of immunodeficiency

Info

Publication number
AU3836489A
AU3836489A AU38364/89A AU3836489A AU3836489A AU 3836489 A AU3836489 A AU 3836489A AU 38364/89 A AU38364/89 A AU 38364/89A AU 3836489 A AU3836489 A AU 3836489A AU 3836489 A AU3836489 A AU 3836489A
Authority
AU
Australia
Prior art keywords
immunodeficiency
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38364/89A
Inventor
Yves Gerard Andre Delatte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WHITECLIFFE LABORATORIES Ltd
Original Assignee
WHITECLIFFE LAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888813641A external-priority patent/GB8813641D0/en
Priority claimed from GB888818271A external-priority patent/GB8818271D0/en
Priority claimed from GB888827618A external-priority patent/GB8827618D0/en
Application filed by WHITECLIFFE LAB Ltd filed Critical WHITECLIFFE LAB Ltd
Publication of AU3836489A publication Critical patent/AU3836489A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU38364/89A 1988-06-09 1989-06-09 Treatment of immunodeficiency Abandoned AU3836489A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8813641 1988-06-09
GB888813641A GB8813641D0 (en) 1988-06-09 1988-06-09 Treatment of immunodeficiency
GB8818271 1988-08-01
GB888818271A GB8818271D0 (en) 1988-08-01 1988-08-01 Treatment of immunodeficiency
GB8827618 1988-11-25
GB888827618A GB8827618D0 (en) 1988-11-25 1988-11-25 Treatments of immunodeficiency

Publications (1)

Publication Number Publication Date
AU3836489A true AU3836489A (en) 1990-01-05

Family

ID=27263938

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38364/89A Abandoned AU3836489A (en) 1988-06-09 1989-06-09 Treatment of immunodeficiency

Country Status (2)

Country Link
AU (1) AU3836489A (en)
WO (1) WO1989011858A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020577A1 (en) * 1995-12-06 1997-06-12 Pharma Pacific Pty. Ltd. Improved therapeutic formulation and method

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200891D0 (en) * 1992-01-16 1992-03-11 Mann Stephen P Formulation of microorganisms
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
IT1274654B (en) * 1995-02-28 1997-07-18 Newpharma Srl ASSOCIATIONS OF LACTIC FERMENTS AND SACCHAROMETIC LYSATES THEIR THERAPEUTIC USE AND COMPOSITIONS CONTAINING THEM
WO1997045530A1 (en) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Use of streptococcus faecium strains and composition containing the same
JP4193269B2 (en) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド New biological purification active lactic acid bacteria preparation
KR100398665B1 (en) * 2000-08-09 2003-09-19 비에이치피에이치 컴퍼니 리미티드 Lactic acid bacterial preparation
EP1510135A1 (en) * 2003-08-26 2005-03-02 Chr. Hansen A/S A farm animal feed product with probiotic enterococcus bacteria
WO2005009139A1 (en) * 2003-07-30 2005-02-03 Chr. Hansen A/S A farm animal product with probiotic enterococcus bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1585863A (en) * 1977-08-24 1981-03-11 Seiken Kai Foundational Juridi Pharmaceutical lactobacillus preparations
GB2072502A (en) * 1980-02-27 1981-10-07 Yakult Honsha Kk Antitumour agent comprising lactobacillus casei
US4591499A (en) * 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
JPH0696538B2 (en) * 1985-12-19 1994-11-30 株式会社アドバンス Anti-carcinogen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020577A1 (en) * 1995-12-06 1997-06-12 Pharma Pacific Pty. Ltd. Improved therapeutic formulation and method

Also Published As

Publication number Publication date
WO1989011858A1 (en) 1989-12-14

Similar Documents

Publication Publication Date Title
AU1676588A (en) Treatment of materials
AU4620789A (en) Treatment of obesity
AU587358B2 (en) Control of retroviruses
AU3478289A (en) Treatment of fibrous materials
AU3072989A (en) Skin treatment composition
AU6979487A (en) Treatment of gases
AU3731489A (en) Pulp treatment methods
AU621673B2 (en) Fabric treatment
AU2163388A (en) Flame treatment
AU1279788A (en) Compounds and treatment
AU3413389A (en) Method of treating retrovirus infection
AU2027388A (en) Tissue put-up
AU3604289A (en) Treatment of arthritis
AU3991189A (en) Elimination of bleach effluents
AU613543B2 (en) Preparation of halofluorobenzenes
AU3836489A (en) Treatment of immunodeficiency
AU6660090A (en) Treatment of depression
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU3964789A (en) Filtering procedure
AU7233987A (en) Treatment of osteoporosis
AU3553489A (en) Novel compounds and treatment
AU8269787A (en) Flyslag treatment
AU7125091A (en) Metal treatment
AU4019489A (en) Surface treatment
AU6414190A (en) Treatment of carbohydrates